SHE:300255

2 stories mentioning SHE:300255Updated 36d ago

Every FINWIRES story that references SHE:300255, newest first.

Changshan Biochemical Pharma Gets Belarus' Registration Certificate for Dalteparin Sodium Injection

Hebei Changshan Biochemical Pharmaceutical (SHE:300255) obtained a pharmaceutical registration certificate from Belarus' drug regulator for its dalteparin sodium injection, according to a Thursday disclosure on the Shenzhen bourse.The drug is used to treat acute deep vein thrombosis and unstable coronary artery diseases.

SHE:300255

Asia60d ago

Hebei Changshan Biochemical Pharmaceutical Gets Kyrgyzstan Nod for Blood Thinning Injection

Drug regulators in Kyrgyzstan approved Hebei Changshan Biochemical Pharmaceutical's (SHE:300255) heparin sodium injection, according to a Thursday disclosure to the Shenzhen bourse.The drug helps treat thrombotic or embolic diseases, acting as a blood thinner that prevents blood clots, the filing said.

SHE:300255

Track with the FINWIRES app suite

FolioX

Track SHE:300255 in your portfolio

WheelAI

Analyze SHE:300255 options with the wheel strategy

StockInsider

See market sentiment on SHE:300255